The price of 22nd Century Group Inc. (NASDAQ:XXII) shares last traded on Wall Street rose 31.08% to $4.85.
Based on available information, 5 analysts follow 22nd Century Group Inc. (NASDAQ:XXII). The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $75.00 and a low of $15.00, we find $45.00. Given the previous closing price of $3.70, this indicates a potential upside of 1116.22 percent. XXII stock price is now -30.28% away from the 50-day moving average and -61.71% away from the 200-day moving average. The market capitalization of the company currently stands at $80.70M.
Among analysts, 0 rate the stock a hold while 5 rate it a buy. Brokers who have rated the stock have averaged $51.00 as their price target over the next twelve months.
With the price target of $5, Alliance Global Partners recently initiated with Buy rating for 22nd Century Group Inc. (NASDAQ: XXII).
In other news, ZERCHER MICHAEL, President and COO sold 370,789 shares of the company’s stock on Aug 31. The stock was sold for $500,565 at an average price of $1.35. Upon completion of the transaction, the President and COO now directly owns 904,938 shares in the company, valued at $4.39 million. Insiders disposed of 686,819 shares of company stock worth roughly $3.33 million over the past 1 year. A total of 0.50% of the company’s stock is owned by insiders.
There have been several recent changes in the stakes of large investors in XXII stock. A new stake in 22nd Century Group Inc. shares was purchased by PINE VALLEY INVESTMENTS LTD LIABILITY CO during the first quarter worth $31,000. PRIVATE ADVISOR GROUP, LLC invested $6,000 in shares of XXII during the first quarter. In the first quarter, CAPITAL MARKET STRATEGIES LLC acquired a new stake in 22nd Century Group Inc. valued at approximately $4,000. METROPOLITAN LIFE INSURANCE CO/NY acquired a new stake in XXII for approximately $3,000. STERLING INVESTMENT COUNSEL, LLC purchased a new stake in XXII valued at around $3,000 in the second quarter.
A candlestick chart of 22nd Century Group Inc. (NASDAQ: XXII) showed a price of $3.9000 on Friday morning. During the past 12 months, 22nd Century Group Inc. has had a low of $2.19 and a high of $31.58. As of last week, the company has a debt-to-equity ratio of 0.21, a current ratio of 2.40, and a quick ratio of 1.80. The fifty day moving average price for XXII is $6.8410 and a two-hundred day moving average price translates $12.6230 for the stock.
The latest earnings results from 22nd Century Group Inc. (NASDAQ: XXII) was released for Mar, 2023. According to the Tobacco Company, earnings per share came in at -$1.2, missing analysts’ expectations of -$1.12 by -0.08. This compares to -$0.82 EPS in the same period last year. The net profit margin was -92.10% and return on equity was -69.40% for XXII. The company reported revenue of $21.96 million for the quarter, compared to $9.04 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 142.81 percent. For the current quarter, analysts expect XXII to generate $24.01M in revenue.
22nd Century Group Inc.(XXII) Company Profile
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
